Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Transcription factor NFAT5 promotes macrophage survival in rheumatoid arthritis
Susanna Choi, … , Chul-Soo Cho, Wan-Uk Kim
Susanna Choi, … , Chul-Soo Cho, Wan-Uk Kim
Published February 13, 2017
Citation Information: J Clin Invest. 2017;127(3):954-969. https://doi.org/10.1172/JCI87880.
View: Text | PDF
Research Article Immunology Inflammation

Transcription factor NFAT5 promotes macrophage survival in rheumatoid arthritis

  • Text
  • PDF
Abstract

Defective apoptotic death of activated macrophages has been implicated in the pathogenesis of rheumatoid arthritis (RA). However, the molecular signatures defining apoptotic resistance of RA macrophages are not fully understood. Here, global transcriptome profiling of RA macrophages revealed that the osmoprotective transcription factor nuclear factor of activated T cells 5 (NFAT5) critically regulates diverse pathologic processes in synovial macrophages including the cell cycle, apoptosis, and proliferation. Transcriptomic analysis of NFAT5-deficient macrophages revealed the molecular networks defining cell survival and proliferation. Proinflammatory M1-polarizing stimuli and hypoxic conditions were responsible for enhanced NFAT5 expression in RA macrophages. An in vitro functional study demonstrated that NFAT5-deficient macrophages were more susceptible to apoptotic death. Specifically, CCL2 secretion in an NFAT5-dependent fashion bestowed apoptotic resistance to RA macrophages in vitro. Injection of recombinant CCL2 into one of the affected joints of Nfat5+/– mice increased joint destruction and macrophage infiltration, demonstrating the essential role of the NFAT5/CCL2 axis in arthritis progression in vivo. Moreover, after intra-articular injection, NFAT5-deficient macrophages were more susceptible to apoptosis and less efficient at promoting joint destruction than were NFAT5-sufficient macrophages. Thus, NFAT5 regulates macrophage survival by inducing CCL2 secretion. Our results provide evidence that NFAT5 expression in macrophages enhances chronic arthritis by conferring apoptotic resistance to activated macrophages.

Authors

Susanna Choi, Sungyong You, Donghyun Kim, Soo Youn Choi, H. Moo Kwon, Hyun-Sook Kim, Daehee Hwang, Yune-Jung Park, Chul-Soo Cho, Wan-Uk Kim

×

Figure 1

Enhanced NFAT5 signature in RA synovial macrophages.

Options: View larger image (or click on image) Download as PowerPoint
Enhanced NFAT5 signature in RA synovial macrophages.
(A) Heatmap display...
(A) Heatmap displaying the differential expression patterns of 1,913 DEGs in CD14+ macrophages from RA-SF (n = 6) compared with normal macrophages (n = 2) differentiated from peripheral CD14+ monocytes. Red and green colors denote upregulation and downregulation, respectively. Mφ, macrophages. (B) Top 10 TFs enriched by up- and downregulated DEGs in RA synovial macrophages. (C) Venn diagram depicting the overlap between DEGs in synovial macrophages from RA patients and those in NFAT5-deficient RA synovial fibroblasts and human endothelial cells. P value indicates the significance of 302 overlapping DEGs, including 176 upregulated and 126 downregulated DEGs. Empirical hypothesis testing based on 100,000 random permutations was performed to determine the P value of the overlapping DEGs. (D) Cellular processes enriched by the DEGs in synovial macrophages from RA patients. Heatmap with violet color gradient represents the level of significance for each cellular process. Dark violet and bright violet refer to high (P < 0.01) and moderate (P < 0.05) enrichment, respectivel. The P values were determined by DAVID software using a hypergeometric test method. The bar graph on the right depicts the percentages of overlap between the DEGs associated with each cellular process and NFAT5 target genes. (E) Enhanced NFAT5 expression in RA synovial macrophages. Synovial macrophages were freshly isolated from synovial fluid of RA patients using anti-CD14 magnetic beads. Normal macrophages were differentiated from peripheral monocytes of healthy subjects. NFAT5 expression was determined by real-time PCR (n = 9), Western blot, and flow cytometric analyses. The gray plot in the flow cytometric graph indicates the isotype control in normal macrophages. NFAT5 mRNA expression is shown as a the fold increase relative to GAPDH mRNA. Data represent the mean ± SD. **P < 0.005 versus normal macrophages, by Mann-Whitney U test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts